Loren Brown serves as US Vice-Chairman, Chair of the Disputes Practice, and a member of the Global Board and US Executive Committee.
Loren has an extensive litigation practice with a concentration in multi-district litigation that often involves large-scale mass tort and class action matters, as well as parallel regulatory and government enforcement proceedings.
Loren has served as national coordinating counsel, tried jury cases, argued appeals and successfully resolved many notable multi-district litigation matters throughout the US. Recent examples include multi-district litigation involving the Cox-2 anti-inflammatory medications Celebrex and Bextra, the smoking cessation medication Chantix, the hormone therapies Premarin and Prempro, the diabetes medication Victoza, the testosterone therapy Depo-T, the cholesterol-lowering medication Lipitor, and the blood thinner Eliquis.